Optimized Viral Dose and Transient Immunosuppression Enable Herpes Simplex Virus ICP0-Null Mutants To Establish Wild-Type Levels of Latency In Vivo
The reduced efficiency with which herpes simplex virus type 1 (HSV-1) mutants establish latent infections in vivo has been a fundamental obstacle in efforts to determine the roles of individual viral genes in HSV-1 reactivation. For example, in the absence of the “nonessential” viral immediate-early...
Na minha lista:
| Publicado no: | J Virol |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
2000
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC112092/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10846077/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.74.13.5957-5967.2000 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|